Deborah M Friedman MD
Professor of Pediatrics, New York Medical College
Join to View Full Profile
94 Old Short Hills Rd# SaintLivingston, NJ 07039
Phone+1 973-322-5691
Fax+1 973-322-5504
Dr. Friedman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
NYU Grossman School of MedicineFellowship, Pediatric Cardiology, 1980 - 1983
Jacobi Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 1977 - 1980
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1977
Certifications & Licensure
NJ State Medical License 1990 - 2025
NY State Medical License 1978 - 2025
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Cardiology
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2002-2014
- Westchester Magazine: Top Doctors Castle Connolly, 2010-2013
- New York Magazine: Top Doctors Castle Connolly, 2005-2008
- Join now to see all
Publications & Presentations
PubMed
- 16 citationsStable to improved cardiac and pulmonary function in children with high-risk sickle cell disease following haploidentical stem cell transplantation.Deborah M. Friedman, Allen J. Dozor, Jordan Milner, Marise D'Souza, Julie-An Talano
Bone Marrow Transplantation. 2021-05-06 - 5 citationsEltrombopag use for refractory immune thrombocytopenia in pregnancy: A case report.Sarah J. Weingarten, Deborah M. Friedman, Anubha Arora
Case Reports in Women's Health. 2021-01-01 - 14 citationsElectrocardiographic QT Intervals in Infants Exposed to Hydroxychloroquine Throughout Gestation.Deborah M. Friedman, Mimi Y. Kim, Nathalie Costedoat-Chalumeau, Robert R. Clancy, Joshua A. Copel
Circulation. Arrhythmia and Electrophysiology. 2020-09-09
Press Mentions
Zosano Pharma Corporation (NASDAQ: ZSAN) Soars 171% After Final Milestone Completed in Long-Term Safety Study of Qtrypta, a Acute Treatment for Migraine DiseaseFebruary 21st, 2019
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
